Curis CRIS
NASDAQ CRIS
$1.61 -0.11 (-6.40%)
At close: Aug 20, 2026 · 4:00 PM EDT

Curis (CRIS) Total Non-Current Liabilities (2010 - 2026)

Curis' (CRIS) quarterly Total Non-Current Liabilities came in at $15.1 million in Q1 2026, down 29.7% YoY from $21.5 million in Q1 2025, and up 3.99% on a QoQ basis from $14.5 million in Q4 2025.

Curis (CRIS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Curis (CRIS) has 17 years of Total Non-Current Liabilities data on file, last reported at $15.1 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 29.7% year-over-year to $15.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.1 million (down 29.7% YoY) and the FY2025 annual result came in at $14.5 million, down 29.75% from the prior year.
  • Total Non-Current Liabilities rose to $15.1 million in Q1 2026, from $14.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $24.0 million in Q3 2024 to a low of $10.6 million in Q1 2023.
  • A 5-year average of $18.0 million and a median of $19.1 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 101.05% — and 2025, when it dropped 29.75%.
  • Tracing CRIS's Total Non-Current Liabilities over 5 years: stood at $19.1 million in 2022, then increased by 23.28% to $23.5 million in 2023, then declined by 12.19% to $20.6 million in 2024, then dropped by 29.75% to $14.5 million in 2025, then climbed by 3.99% to $15.1 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $15.1 million (Q1 2026), $14.5 million (Q4 2025), and $20.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 40.00 Mn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 3.92 Bn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.88 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 4.20 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 1.17 Bn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 9.32 Bn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 724.15 Mn
10 Curis 3.44 Mn -2.18 Mn - 13.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.08 Mn
Dec 31, 2025 14.50 Mn
Sep 30, 2025 20.65 Mn
Jun 30, 2025 20.42 Mn
Mar 31, 2025 21.46 Mn
Dec 31, 2024 20.65 Mn
Sep 30, 2024 24.00 Mn
Jun 30, 2024 21.68 Mn
Mar 31, 2024 21.23 Mn
Dec 31, 2023 23.51 Mn
Sep 30, 2023 15.54 Mn
Jun 30, 2023 11.85 Mn
Mar 31, 2023 10.56 Mn
Dec 31, 2022 19.07 Mn
Sep 30, 2022 16.84 Mn
Jun 30, 2022 15.54 Mn
Mar 31, 2022 12.63 Mn
Dec 31, 2021 17.80 Mn
Sep 30, 2021 14.01 Mn
Jun 30, 2021 12.58 Mn